TNF Pharmaceuticals, Inc. (TNFA) Stock Overview
Explore TNF Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
TNF Pharmaceuticals, Inc. (TNFA)
Key Financials
Key Financials
Market Cap
9.2M
P/E Ratio
-0.24
EPS (TTM)
$-202.00
ROE
-0.58%
TNFA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of TNF Pharmaceuticals, Inc. (TNFA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1.54.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.24 and a market capitalization of 9.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.